Live Breaking News & Updates on கொலராடோ விரிவான புற்றுநோய் மையம்

Stay updated with breaking news from கொலராடோ விரிவான புற்றுநோய் மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

For young patients with breast cancer, fertility concerns influence endocrine therapy decisions, study finds

Concerns about fertility often influence how young women with breast cancer approach treatment decisions and are a reason for forgoing or delaying. ....

United States , Dana Farber Cancer Institute , Rullam Tamimi , Susang Komen , Lidia Schapira , Philipd Poorvu , Sharii Gelber , Dana Farber Shoshana Rosenberg , Ann Partridge , Annh Partridge , Breast Cancer Research Foundation , Beth Israel Deaconess Medical Center , Sheba Medical Center , Pinchas Borenstein Talpiot Medical Leadership Program , Stanford Cancer Institute , Agency For Healthcare Research , University Of Colorado Comprehensive Cancer Center , Tal Sella , Young Women , Breast Cancer Study , Principal Investigator , Shoshana Rosenberg , Mayo Clinic , Weill Cornell Medicine , Massachusetts General Hospital , Colorado Comprehensive Cancer Center ,

For young breast cancer patients, fertility concerns influence therapy decisions

E-Mail
BOSTON - Concerns about fertility often influence how young women with breast cancer approach treatment decisions and are a reason for forgoing or delaying hormone-blocking therapy, a new study by Dana-Farber Cancer Institute investigators shows.
The findings, published online today by the journal
Cancer, reinforce the need for physicians to talk with patients about their fertility-related priorities and address them in treatment plans, the study authors write. Such conversations are important not only at the start of treatment but during its entire course, as patients goals and preferences may change over time.
Young women with breast cancer face unique challenges, including issues surrounding fertility, says the study s lead author Tal Sella, MD, of Dana-Farber. For many premenopausal women with hormone receptor-positive breast cancer, long-term endocrine therapy [which blocks hormones that feed the cancer s growth] may prevent patients from having ....

United States , Dana Farber Cancer Institute , Rullam Tamimi , Susang Komen , Lidia Schapira , Philipd Poorvu , Sharii Gelber , Dana Farber Shoshana Rosenberg , Ann Partridge , Annh Partridge , Breast Cancer Research Foundation , Beth Israel Deaconess Medical Center , Sheba Medical Center , Pinchas Borenstein Talpiot Medical Leadership Program , Stanford Cancer Institute , Agency For Healthcare Research , University Of Colorado Comprehensive Cancer Center , Tal Sella , Young Women , Breast Cancer Study Principal Investigator , Shoshana Rosenberg , Mayo Clinic , Weill Cornell Medicine , Massachusetts General Hospital , Colorado Comprehensive Cancer Center , Beth Israel Deaconess Medical ,